ASCO25: Johnson & Johnson reports data from Phase I trial of prostate cancer drug
Clinical Trials Arena
Mon, 06/2/25 - 11:09 am
JNJ
clinical trials
ASCO 2025
pasritamig
bispecific antibodies
metastatic castration-resistant prostate cancer
Diakonos Oncology secures $20m for Phase II trial of glioblastoma treatment
Clinical Trials Arena
Mon, 06/2/25 - 11:07 am
Diakonos Oncology
funding
dubodencel
glioblastoma
Sales Firm In Orlando Is Seeking Candidates With Pharmaceutical Sales Experience For Entry Level Sales Positions!!! - The White Label Firm - Alafaya, Florida, United States
Mon, 06/2/25 - 11:04 am
Pharmaceutical Sales- Associate Territory Manager- Cardiometabolic Health - Eli Lilly and Company - Washington DC, District of Columbia, United States
Mon, 06/2/25 - 11:04 am
Specialty Pharmaceutical Sales Rep/Clinical Specialist (LA North) - Indivior Treatment Services - Los Angeles, California, United States
Mon, 06/2/25 - 11:04 am
Sr. Pharmaceutical Sales Specialist, Specialty Care CVRM, Charlotte, NC - AstraZeneca - Charlotte, North Carolina, United States
Mon, 06/2/25 - 11:04 am
Pharmaceutical Sales Specialist - Specialty Care-Savannah, GA - AstraZeneca - Savannah, Georgia, United States
Mon, 06/2/25 - 11:04 am
Pharmaceutical Sales Specialist, CVRM Specialty – Springfield, IL - AstraZeneca - Springfield, Illinois, United States
Mon, 06/2/25 - 11:04 am
Pharmaceutical Sales District Manager - Texas/Florida - EVERSANA - Dallas, Texas, United States
Mon, 06/2/25 - 11:04 am
Primary Care Pharmaceutical Sales Specialist - National Sales Network (NSN) - AstraZeneca - United States
Mon, 06/2/25 - 11:04 am
Pharmaceutical Sales Specialist - Chicago - Alcon Vision. Company - Remote
Mon, 06/2/25 - 11:04 am
ASCO: Bicara ties antibody to 46% 2-year survival rate for head and neck cancer subset
Fierce Biotech
Mon, 06/2/25 - 11:04 am
Bicara Therapeutics
ASCO 2025
ficerafusp alfa
Keytruda
squamous cell carcinoma of the head and neck
BioNTech flips its cancer bispecific to BMS for a big profit
Pharmaphorum
Mon, 06/2/25 - 11:00 am
BioNTech
Bristol Myers Squibb
bispecific antibodies
BNT327
Small-Cell Lung Cancer
At ASCO, Enhertu cements growing role in stomach cancer care
BioPharma Dive
Mon, 06/2/25 - 10:58 am
ASCO 2025
AstraZeneca
Daiichi Sankyo
stomach cancer
Enhertu
May 30 2025 - #ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
Fri, 05/30/25 - 11:52 am
#ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
BioSpace
Fri, 05/30/25 - 11:49 am
ASCO 2025
chicago
Pfizer
Astellas
Evopoint Biosciences
Summit Therapeutics
Merck
Summit’s bispecific misses survival endpoint in global phase III trial but analysts remain optimistic
BioSpace
Fri, 05/30/25 - 11:46 am
Summit Therapeutics
ivonescimab
PD-1xVEGF
clinical trials
Merck plays lion tamer, taking middle dose of ROR ADC forward in relapsed or refractory DLBCL
Fierce Biotech
Fri, 05/30/25 - 11:39 am
Merck
zilovertamab vedotin
lymphoma
relapsed or refractory diffuse large B cell lymphoma
Roche links BTK inhibitor to low relapse rate across 96-week multiple sclerosis trial
Fierce Biotech
Fri, 05/30/25 - 11:29 am
Roche
fenebrutinib
Btk inhibitors
MS
clinical trials
multiple sclerosis
ASCO25: Merck KGaA’s ADC shows safety and tolerability in colorectal cancer trial
Clinical Trials Arena
Fri, 05/30/25 - 11:28 am
Merck KGaA
precemtabart tocentecan
clinical trials
ASCO 2025

Pages